Skip to main content
    A

    Aveanna Healthcare Holdings Inc (AVAH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $11.65
    +0.02 (+0.17%)

    Market Cap: $2.51B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Aveanna Healthcare Holdings Inc (AVAH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Aveanna Healthcare Holdings (AVAH) has a market cap of $2.51B and an enterprise value of $3.82B. Its share count is up 3.14% from a year earlier. Its net debt of $1.30B equals 51.90% of its market cap.

    Total Valuation

    Enterprise value is 51.90% above the market cap, as debt exceeds cash.

    Market Cap$2.51B
    Enterprise Value$3.82B
    Latest price (Nov 17, 2026)$11.65

    Key Dates

    The next earnings report is expected on Mar 19, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 19, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.94% in the quarter ended Sep 30, 2026 and grew 8.88% a year over 2 years.

    Shares Outstanding229.22M
    Shares Change (YoY)+3.14%
    Shares Change (QoQ)+1.94%
    Share Count Growth (2Y CAGR)+8.88%

    Valuation Ratios

    Sales and book value multiples are 1.0x and 7.9x. Its year-end P/E ranged from 14.1x to 91.4x from 2021 to 2025.

    P/E Ratio14.9x
    Forward P/E13.9x
    P/S Ratio1.0x
    Forward P/S0.9x
    P/B Ratio7.9x
    P/FCF Ratio13.5x
    P/OCF Ratio12.1x
    PEG Ratio0.7

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.4x EBITDA and 20.1x free cash flow.

    EV / Earnings12.5x
    EV / Sales1.4x
    EV / EBITDA11.4x
    EV / EBIT11.8x
    EV / FCF20.1x

    Price Statistics

    The stock is up 37.87% over 52 weeks and trades 9.97% below its 50-day average.

    Beta (1Y)0.58
    52-Week Change+37.87%
    1-Month Change-6.35%
    3-Month Change-11.47%
    6-Month Change+52.69%
    5-Year Change+70.47%
    Total Return (1Y)+37.87%
    Total Return (3Y CAGR)+74.02%
    Total Return (5Y CAGR)+9.30%
    Return vs SPY (1Y)+26.47%
    Max Drawdown (1Y)-36.27%
    Max Drawdown (3Y)-39.44%
    Sharpe Ratio (1Y)0.68
    Correlation with SPY (1Y)0.17
    50-Day Average$12.94
    200-Day Average$9.47
    52-Week Range$5.93 to $14.71
    RSI (14 Days)35.3
    Average Volume (20 Days)2.36M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.23x current liabilities, and total debt is 4.45x shareholder equity.

    Current Ratio1.23x
    Quick Ratio1.23x
    Debt / Equity4.45x
    Debt / EBITDA4.32x
    Debt / FCF7.60x
    Interest Coverage2.76x

    Returns and Efficiency

    Return on invested capital is 17.52% over the last 12 months, against a 5-year average of -4.77%.

    Return on Equity (ROE)90.73%
    Return on Assets (ROA)13.87%
    Return on Invested Capital (ROIC)17.52%
    Return on Capital Employed (ROCE)18.44%
    ROA (5Y Average)-8.30%
    ROIC (5Y Average)-4.77%
    Asset Turnover1.33x
    Receivables Turnover7.89x

    Scores

    AVAH has an Altman Z-Score of 1.96, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score1.96
    Altman Z ZoneGrey
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $2.68B over the last 12 months is up 16.84% from the 12 months before.

    Revenue$2.68B
    Revenue Growth (YoY)+16.84%
    Gross Profit$858.25M
    Operating Income$316.75M
    Pretax Income$205.47M
    Net Income$306.15M
    EBITDA$347.64M
    EBIT$322.11M
    Reported EPS (TTM)$0.78

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 15.27% of the $2.21B in total assets.

    Cash and Equivalents$197.84M
    Total Debt$1.50B
    Net Debt$1.30B
    Net Debt Per Share$5.69
    Working Capital$105.59M
    Shareholder Equity$337.42M
    Book Value Per Share$1.47
    Tangible Book Value-$1.04B
    Total Assets$2.21B
    Total Liabilities$1.87B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $9.70M of capital spending, operating cash flow left $197.54M of free cash flow.

    Operating Cash Flow$207.24M
    Capital Expenditures$9.70M
    Free Cash Flow$197.54M
    FCF Per Share$0.90
    Depreciation and Amortization$30.08M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 11.83%, against a 5-year average of -3.97%.

    Gross Margin32.07%
    Operating Margin11.83%
    Pretax Margin7.68%
    Net Margin11.44%
    EBITDA Margin12.99%
    EBIT Margin12.04%
    FCF Margin7.38%
    Gross Margin (5Y Average)31.83%
    Operating Margin (5Y Average)-3.97%
    Net Margin (5Y Average)-8.48%

    Growth

    Revenue grew 10.82% a year over 3 years, and EPS 287.09% a year.

    Revenue Growth (3Y CAGR)+10.82%
    Revenue Growth (5Y CAGR)+10.23%
    EPS Growth (3Y CAGR)+287.09%
    EPS Growth (5Y CAGR)+46.31%
    FCF Growth (5Y CAGR)+3.15%

    Revenue and profit by year

    Dividends and Yields

    AVAH does not pay a dividend. Its free cash flow yield is 7.40%.

    Earnings Yield6.71%
    FCF Yield7.40%
    Shareholder Yield0.00%

    Peer Position

    Against 11 similar companies, AVAH has the 10th highest P/E and the 2nd highest ROIC.

    P/E Ratio14.9x vs 28.6x median
    P/S Ratio1.0x vs 1.6x median
    ROIC17.52% vs 8.68% median
    Revenue Growth (Trailing 4 Quarters, YoY)+16.84% vs +7.99% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 9.46% and EPS growth at 25.31% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+9.46%
    EPS Growth Forecast (2Y CAGR)+25.31%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AVAH

    What is AVAH's market cap?

    Aveanna Healthcare Holdings has a market cap of $2.51B. Its enterprise value, which adds debt and subtracts cash, is $3.82B.

    What is AVAH's P/E ratio?

    Aveanna Healthcare Holdings has a trailing P/E ratio of 14.9x and a forward P/E of 13.9x.

    How many shares of AVAH are outstanding?

    Aveanna Healthcare Holdings has 229.22M shares outstanding. The count is up 3.14% from a year earlier.

    Does AVAH pay a dividend?

    No. Aveanna Healthcare Holdings does not pay a dividend.

    How much debt does AVAH have?

    Aveanna Healthcare Holdings has $1.50B of total debt and $197.84M of cash and equivalents, a net debt position of $1.30B.